These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 24559619)
1. Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study. Tartagni MV; Alrasheed H; Damiani GR; Montagnani M; De Salvia MA; De Pergola G; Tartagni M; Loverro G J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):161-5. PubMed ID: 24559619 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of a 12-month treatment with finasteride in idiophathic and polycystic ovary syndrome-associated hirsutism. Petrone A; Civitillo RM; Galante L; Giannotti F; D'Antò V; Rippa G; Tolino A Clin Exp Obstet Gynecol; 1999; 26(3-4):213-6. PubMed ID: 10668160 [TBL] [Abstract][Full Text] [Related]
3. The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism. Lakryc EM; Motta EL; Soares JM; Haidar MA; de Lima GR; Baracat EC Gynecol Endocrinol; 2003 Feb; 17(1):57-63. PubMed ID: 12724020 [TBL] [Abstract][Full Text] [Related]
4. Finasteride in the treatment of hirsutism: new therapeutic perspectives. Tolino A; Petrone A; Sarnacchiaro F; Cirillo D; Ronsini S; Lombardi G; Nappi C Fertil Steril; 1996 Jul; 66(1):61-5. PubMed ID: 8752612 [TBL] [Abstract][Full Text] [Related]
5. Comparison of finasteride versus flutamide in the treatment of hirsutism. Falsetti L; Gambera A; Legrenzi L; Iacobello C; Bugari G Eur J Endocrinol; 1999 Oct; 141(4):361-7. PubMed ID: 10526249 [TBL] [Abstract][Full Text] [Related]
6. Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women. Tartagni M; Schonauer MM; Cicinelli E; Petruzzelli F; De Pergola G; De Salvia MA; Loverro G Fertil Steril; 2004 Sep; 82(3):752-5. PubMed ID: 15374729 [TBL] [Abstract][Full Text] [Related]
7. [Finasteride and flutamide in the treatment of hirsutism]. Falsetti L; De Fusco D; Rosina B Minerva Ginecol; 1997 Oct; 49(10):463-8. PubMed ID: 9463180 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects. Meczekalski B; Slopien R; Warenik-Szymankiewicz A Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812 [TBL] [Abstract][Full Text] [Related]
9. Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up. Castello R; Tosi F; Perrone F; Negri C; Muggeo M; Moghetti P Fertil Steril; 1996 Nov; 66(5):734-40. PubMed ID: 8893676 [TBL] [Abstract][Full Text] [Related]
10. Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism. Moghetti P; Castello R; Magnani CM; Tosi F; Negri C; Armanini D; Bellotti G; Muggeo M J Clin Endocrinol Metab; 1994 Oct; 79(4):1115-21. PubMed ID: 7962284 [TBL] [Abstract][Full Text] [Related]
11. Low-dose (2.5 mg/day) finasteride treatment in hirsutism. Bayram F; Müderris I; Güven M; Ozçelik B; Keleştimur F Gynecol Endocrinol; 2003 Oct; 17(5):419-22. PubMed ID: 14710591 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Tartagni M; Schonauer LM; De Salvia MA; Cicinelli E; De Pergola G; D'Addario V Fertil Steril; 2000 Apr; 73(4):718-23. PubMed ID: 10731531 [TBL] [Abstract][Full Text] [Related]
13. Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism. Ciotta L; Cianci A; Calogero AE; Palumbo MA; Marletta E; Sciuto A; Palumbo G Fertil Steril; 1995 Aug; 64(2):299-306. PubMed ID: 7615107 [TBL] [Abstract][Full Text] [Related]
14. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women. Wong IL; Morris RS; Chang L; Spahn MA; Stanczyk FZ; Lobo RA J Clin Endocrinol Metab; 1995 Jan; 80(1):233-8. PubMed ID: 7829618 [TBL] [Abstract][Full Text] [Related]
15. Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism. Bayram F; Müderris II; Güven M; Keleştimur F Eur J Endocrinol; 2002 Oct; 147(4):467-71. PubMed ID: 12370107 [TBL] [Abstract][Full Text] [Related]
16. A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome. Chung JP; Yiu AK; Chung TK; Chan SS J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):166-71. PubMed ID: 24656700 [TBL] [Abstract][Full Text] [Related]
17. The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism. Demirci T; Cengiz H; Varım C; Çetin S Turk J Med Sci; 2020 Dec; 50(8):1976-1982. PubMed ID: 32892549 [TBL] [Abstract][Full Text] [Related]
18. Effect of finasteride in idiopathic hirsutism. Faloia E; Filipponi S; Mancini V; Di Marco S; Mantero F J Endocrinol Invest; 1998 Nov; 21(10):694-8. PubMed ID: 9854686 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women. Falsetti L; Rosina B; De Fusco D Eur J Endocrinol; 1998 Apr; 138(4):421-4. PubMed ID: 9578510 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. Zacchè MM; Caputo L; Filippis S; Zacchè G; Dindelli M; Ferrari A Gynecol Endocrinol; 2009 Aug; 25(8):508-13. PubMed ID: 19551544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]